We are focused on unlocking the pharmaceutical potential of Ketamine for rare and near-rare neurological and pain disorders, including Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Complex Regional Pain Syndrome.
"The product candidates described on this website are investigational and have not been approved by the U.S. Food and Drug Administration (FDA) or any other regulatory authority. Safety and efficacy have not been established."
Connect With Us
PharmaTher Holdings Ltd. 82 Richmond Street East Toronto, Ontario Canada M5C 1P1